NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/04/2024
Back to search
Official data from USPTO
IMIGINE PMB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079334190Class
1, 5, 9, 10, 44
Filing
79334190
Registration
7045428
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/04/2024
Trademark type
Combined
Nice classes
1, 5, 9, 10, 44
Filing date
09/14/2021
Registration date
05/09/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/09/2023
Last transaction
05/09/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
FR
Examiner
PANDIT, ROHINI
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized text "IMIGINE PMB". A line appears under the letters "IMIGIN".
Holders and representatives
Holders
PMB
Representatives
Nick Guinn Gunn, Lee & Cave, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Radioactive elements for scientific use
Class 5
isotopes for medical use; radioactive substances for medical use
Class 9
Chemistry apparatus and instrumentsa microfluidic cartridge with reagents and chemical solvents for use in microfluidic synthesis of radiopharmaceuticalsnot for medical purposes
Class 10
Medical apparatus for diagnostic radiopharmaceutical use; Medical apparatus for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing
Class 44
Medical equipment rental
Publications
History of USPTO decisions and trademark events.
31 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/04/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/14/2023
FIMP
FINAL DISPOSITION PROCESSED
08/14/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/09/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2023
PUBO
PUBLISHED FOR OPPOSITION
02/21/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/21/2022
RFNT
REFUSAL PROCESSED BY IB
08/02/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/14/2022
RFRR
REFUSAL PROCESSED BY MPU
07/14/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/24/2022
CNRT
NON-FINAL ACTION WRITTEN
06/23/2022
DOCK
ASSIGNED TO EXAMINER
06/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/24/2022
Continuous trademark protection
Get notified about every new filing that threatens IMIGINE PMB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.